SCHOOL OF MEDICINE | HEALTH SCIENCES | HSLS | FIND PEOPLE AT PITT  
Peter A. Friedman, PhD
Professor & Vice Chair, Academics
E1356 Biomedical Science Tower
200 Lothrop Street, Pittsburgh, PA 15261

Email:
paf10@pitt.edu
Phone: 412-383-7783

Fax: 412-648-1945


Education
BA (Zoology), Syracuse University, 1970.
PhD (Pharmacology), SUNY Upstate Medical Center, 1975.
Postdoctoral Fellow (Pharmacology), University of Lausanne, Switzerland, 1975-1977.
Postdoctoral Fellow (Physiology), Cornell University Medical College, 1977-1979.


Research Areas
Receptor Pharmacology
Signal Transduction
Photo of Peter A. Friedman, PhD

Studies in the Friedman laboratory focus on regulation of parathyroid hormone receptor signaling and regulated trafficking. PTH controls extracellular calcium and phosphate homeostasis. PTH effects on kidney and bone are mediated by its cognate receptor, the type I PTH receptor (PTH1R). Key advances have been made in understanding cell-specific PTH1R signaling and trafficking. Recent observations indicate that PTH1R activation, desensitization and endocytosis are mediated through distinct structural states that derive from specific interactions between ligand and receptor. Agonist- or antagonist-occupied receptor states induce discrete conformations with accessibility to intracellular receptor domains. The differential or inducible involvement of these domains in coupling to G proteins may represent a molecular basis for ligand-selective responses not only for the PTH1R, but also for other G protein-coupled receptors. Current work is directed at elucidating the molecular and structural mechanisms of how cytoplasmic scaffold proteins such as NHERF1 and Dishevelled legislate cell-, ligand-, and stage-specific receptor trafficking.





Important Publications
Ardura JA, SC Watkins, JP Vilardaga and PA Friedman.  Dynamic Na+-H+ exchanger regulatory factor-1 association and dissociation regulate PTH receptor trafficking at membrane microdomains.  J Biol Chem 286:35061-35070, 2011.
Alonso V, CE Magyar, B Wang, A Bisello and PA Friedman.  Ubiquitination-deubiquitination balance dictates ligand-stimulated PTHR sorting.  J Bone Miner Res Aug 23.  doi:  10.1002/jbmr.494 [Epub ahead of print], 2011.
Ardura JA and PA Friedman.  Regulation of GPCR function by NHERF adapter proteins.  Pharmacol Rev 63:882-900, 2011.
Friedman PA.  Agents affecting mineral ion homeostasis and bone turnover.  In:  Goodman & Gilman's The Pharmacological Basis of Therapeutics, edited by Brunton LL, Chabner B and Knollmann B:  New York:  McGraw Hill, 2011, p. 1275-1306.
Liu L, PH Schlesinger, NM Slack, PA Friedman and HC Blair.  High capacity Na+/H+ exchange activity in mineralizing osteoblasts.  J Cell Physiol 226:1702-1712, 2011.
Wang B, JA Ardura, G Romero, Y Yang, RA Hall and PA Friedman.  Na/H exchanger regulatory factors control PTH receptor signaling by differential activation of G alpha protein subunits.  J Biol Chem 285:26976-26986, 2010.
Wheeler DS, SR Barrick, M Grubisha, AM Brufsky, PA Friedman and G Romero.  Direct interaction between NHERF1 and Frizzled regulates beta-catenin signaling.  Oncogene 30:32-42, 2011.
Klenk C, T Vetter, A Zurn, JP Vilardaga, PA Friedman, B Wang and MJ Lohse.  NHERF1, beta-arrestin, and the parathyroid hormone receptor form a ternary signaling complex.  J Biol Chem 285:30355-30362, 2010.




Back to Top